| Novo Nordisk Pharma AG - Rybelsus N 4 mg, Tabletten |
| 69865 | | 02 | | Rybelsus N 4 mg | | Tabletten | | A10BJ06 | | Semaglutide | | 28.11.2025 | | |
|
| Composition |
| semaglutidum 4 mg, natrii salcaprozas corresp. natrium 8 mg, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Semaglutidum | 4 mg |
| | BAG: Active Agent | Dose |
|---|
| Semaglutidum | 4 mg |
| | | | Inactive agents |
|---|
| Magnesii Stearas | | Natrii Salcaprozas | | Pro Compresso |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 30 | 89.26 | 113.50 | B | SL | No | | 003 | 90 | 267.78 | 307.65 | B | SL | No |
|
